Stevanato Group S.p.A (STVN) Research & Development (2020 - 2026)
Stevanato Group S.p.A's Research & Development came in at $7.22 million for the quarter ended Jun 30, 2026, up 5.5% from $6.84 million a year earlier and up 5.6% from the prior quarter.
Stevanato Group S.p.A (STVN) Research & Development (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Stevanato Group S.p.A reported Research & Development of $29.75 million, up 13.0% year-over-year; for the year ended Dec 31, 2025, it was $29.61 million, down 13.6% from the prior year.
- Research & Development carries a five-year compound annual growth rate of 8.3% (years ended Dec 2020 to Dec 2025).
- Going back by year, Research & Development was $34.28 million in the year ended Dec 31, 2024 (-11.2%), $38.59 million in the year ended Dec 31, 2023 (+6.5%), $36.24 million in the year ended Dec 31, 2022 (+3.4%) and $35.05 million in the year ended Dec 31, 2021 (+76.5%).
- The five-year range for quarterly Research & Development is $5.98 million (the quarter ended Dec 31, 2024) to $11.68 million (the quarter ended Mar 31, 2024).
- Year-over-year, Research & Development has increased for four consecutive quarters, with an average decline of 11.4% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in the quarter ended Dec 31, 2021 (growth of 86.0%), and the weakest in the quarter ended Mar 31, 2025 (a decline of 46.6%).
- Business Quant data shows STVN's Research & Development at $6.84 million (quarter ended Mar 31, 2026), $6.75 million (quarter ended Dec 31, 2025) and $8.94 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 364.00 Mn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 892.00 Mn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 412.00 Mn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 370.60 Mn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 771.00 Mn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 434.00 Mn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 554.00 Mn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 278.90 Mn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 258.00 Mn |
| 10 | Stevanato Group S.p.A | 6.34 Bn | 5.78 Bn | 100.91 Mn | 7.22 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.22 Mn |
| Mar 31, 2026 | 6.84 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 8.94 Mn |
| Jun 30, 2025 | 6.84 Mn |
| Mar 31, 2025 | 6.24 Mn |
| Dec 31, 2024 | 5.98 Mn |
| Sep 30, 2024 | 7.26 Mn |
| Jun 30, 2024 | 9.41 Mn |
| Mar 31, 2024 | 11.68 Mn |
| Dec 31, 2023 | 10.87 Mn |
| Sep 30, 2023 | 9.46 Mn |
| Jun 30, 2023 | 9.11 Mn |
| Mar 31, 2023 | 9.18 Mn |
| Dec 31, 2022 | 10.81 Mn |
| Sep 30, 2022 | 7.68 Mn |
| Jun 30, 2022 | 9.07 Mn |
| Mar 31, 2022 | 8.63 Mn |
| Dec 31, 2021 | 10.87 Mn |
| Sep 30, 2021 | 8.72 Mn |
Stevanato Group S.p.A Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=STVN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "STVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=STVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();